Research Type: Extramural
Dr Cheung’s project will be the first to identify and investigate the risk factors for the development of some childhood cancers.
This research will pave the way for the development of a less invasive and personalised diagnostic tests to detect cancer relapse in children with ALL.
A/Prof Buchanan and his team will determine how the gut bacteria causes bowel cancer in younger adults by looking at samples.
Alongside a clinical trial of ribociclib for prostate cancer, Professor Butler and her team will identify biomarkers that can be used to identify which patients this new drug is likely to benefit.
Researchers will test a more targeted treatment approach in greatly improving outcomes for individual children with advanced neuroblastoma.
Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.
Dr Jeremy Booth and his team will use tracking technology during radiation treatment for prostate, liver and pancreas cancer patients.
Dr Tiffen hopes their research will deepen our understanding of the epigenetics of melanoma, as well as identifying potential new treatment approaches to improve outcomes for patients with advanced melanoma.
Researchers will investigate a new treatment approach that combines a new drug delivery method capable of specifically targeting the liver.
Researchers will test a dual treatment approach that targets collagen production in pancreatic cancer tumours.